BACKGROUND: While the use of the levonorgestrel intrauterine device (LNG-IUD) is well
established in the adult population, there have been no research studies specifically on the …

OBJECTIVE: To assess the 5-year contraceptive efficacy and safety of a levonorgestrel
(LNG) 52-mg intrauterine system (IUS) from an ongoing 10-year phase 3 contraceptive trial …

Unintended pregnancy is a significant global problem. In 2008, there were over 100 million
unplanned pregnancies worldwide, representing approximately 41% of global conceptions …

Evaluation of: Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, Phase II study
describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing …

STUDY QUESTION What is the bleeding pattern during second consecutive levonorgestrel-
releasing intrauterine system (LNG-IUS) use? SUMMARY ANSWER Consecutive use of …

Objective To assess 3-year data on the efficacy and safety of a new 52-mg levonorgestrel
intrauterine contraceptive (LNG20) designed for up to 7 years use. Study Design Nulliparous …

BACKGROUND: Heavy menstrual bleeding (HMB) is the most common complaint of women
seeking gynecological care. Treatments included surgical or medical options including …

STUDY OBJECTIVE: The purpose of this study was to evaluate our adolescent patient
population who had received a levonorgestrel intrauterine system (LNG-IUS) at or after the …

Objective: An epidemiological survey was carried out in Finland to establish the
performance of the levonorgestrel intrauterine system (LNG-IUS) in a large population of …

Objective The objective was to evaluate amenorrhea patterns and predictors of amenorrhea
during the first year after levonorgestrel 52 mg intrauterine system (IUS) placement. Study …